Neuroendocrine tumours trials in United States
89 trials · From ClinicalTrials.gov, checked 10 Nov 2026. Ask the study team whether a trial fits you.
No phaseRecruitingResearch participation
Natural History of Familial Carcinoid Tumor
- Where
- Bethesda
- Age
- 18 years to 100 years
- People
- 1,600
- Run by
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
See details and how to joinNCT00646022Registry updated 2026-11-09
No phaseEnrolling by invitationResearch participation
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
- Where
- Bethesda
- Age
- 18 years and over
- People
- 1,150
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT00923026Registry updated 2026-11-09
Phase 2RecruitingTrial-stage medicine
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 332
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT01174121Registry updated 2026-11-09
Phase 1RecruitingTrial-stage medicine
A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06041516Registry updated 2026-11-09
Phase 2RecruitingTrial-stage medicine
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 60
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06406465Registry updated 2026-11-09
Phase 2RecruitingTrial-stage medicine
Study of CTX-471 in Patients With Neural Cell Adhesion Molecule (NCAM) Positive Neuroendocrine Neoplasms
- Where
- Seattle, St Louis
- Age
- 18 years and over
- People
- 58
- Run by
- Compass Therapeutics
See details and how to joinNCT07684170Registry updated 2026-11-09
Phase 2/3RecruitingTrial-stage medicine
Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung
- Where
- ‘Aiea, Ames, Anaconda, Anaheim, Anchorage, Ankeny, Ann Arbor, Auburn, Aurora, Baldwin Park, Baton Rouge, Battle Creek, Bellflower, Bend, Berkeley, Billings, Boone, Bridgeport, Brighton, Brownstown, Buffalo, Burlington, Burnsville, Cameron Park, Canton, Cape Girardeau, Carmichael, Carroll, Cary, Centralia, Chambersburg, Charleston, Charlotte, Chelsea, Chicago, Clackamas, Clinton, Clinton Township, Clive, Coeur d'Alene, Columbus, Concord, Creston, Crown Point, Dallas, Danville, Dearborn, Decatur, DeKalb, Denver, Derby, Des Moines, Detroit, Duluth, Durham, East China Township, Eau Claire, Edina, Effingham, Elk Grove, Ephrata, ‘Ewa Beach, Fairfield, Farmington Hills, Flint, Fontana, Fort Dodge, Fort Lauderdale, Fort Worth, Fremont, Gastonia, Geneva, Gettysburg, Glastonbury, Glenview, Goldsboro, Grand Rapids, Grayslake, Great Falls, Greenwich, Grosse Pointe Woods, Guilford, Hanover, Harbor City, Hartford, Harvey, Honolulu, Houston, Irvine, Jackson, Jacksonville, Jefferson, Joplin, Kalamazoo, Kalispell, La Crosse, Lake Forest, Lansing, Lawton, Lebanon, Littleton, Livonia, Los Angeles, Macomb, Marshalltown, Marshfield, Mattoon, Metairie, Milwaukee, Minneapolis, Minocqua, Missoula, Modesto, Morgantown, Mountain View, Mount Vernon, Muskegon, Nampa, Nashville, Newberg, New Haven, New Lenox, New Orleans, New York, Niles, Normal, North Haven, Norton Shores, Novi, O'Fallon, Oklahoma City, Ontario, Oregon City, Orland Park, Palo Alto, Panorama City, Parker, Peabody, Phoenix, Pinehurst, Pontiac, Portland, Post Falls, Raleigh, Rapid City, Reed City, Rice Lake, Richardson, Riverside, Rochester, Rockford, Rock Hill, Rocklin, Roseville, Royal Oak, Sacramento, Saint Johnsbury, Saint Joseph, Saint Louis Park, Saint Paul, Salt Lake City, San Diego, Sandpoint, San Francisco, San Marcos, Santa Cruz, Santa Rosa, Seattle, Shakopee, Shelby, Springfield, Stamford, Stevens Point, St Louis, Stony Brook, Sunnyvale, Tampa, Toledo, Torrington, Traverse City, Troy, Trumbull, Urbana, Vallejo, Warren, Warrenville, Waterbury, Waterford, Waukee, West Bloomfield, West Des Moines, Westerly, Weston, Woodland, Woodland Hills, Wyandotte, Wyoming, York, Yorkville, Ypsilanti
- Age
- 18 years and over
- People
- 189
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05058651Registry updated 2026-11-06
Phase 2RecruitingResearch participation
At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Where
- Grand Forks, Jacksonville
- Age
- 18 years and over
- People
- 220
- Run by
- Mayo Clinic
See details and how to joinNCT05969860Registry updated 2026-11-06
Phase 3RecruitingTrial-stage medicine
Somatostatin Analogues vs. Observation After Peptide Receptor Radionuclide Therapy (PRRT) in Nonfunctional Neuroendocrine Neoplasms
- Where
- San Francisco, St Louis
- Age
- 18 years and over
- People
- 240
- Run by
- Washington University School of Medicine
See details and how to joinNCT07842172Registry updated 2026-11-06
Phase 2RecruitingTrial-stage medicine
Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
- Where
- Ankeny, Aventura, Beverly Hills, Birmingham, Boston, Chicago, Cleveland, Columbus, Coral Gables, Deerfield Beach, Des Moines, Durham, Loma Linda, Los Angeles, Miami, Nashville, New Lenox, Orland Park, Philadelphia, Pittsburgh, Plantation, Rochester, Salt Lake City, San Francisco, St Louis, Torrance, Washington D.C.
- Age
- 18 years and over
- People
- 70
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT04665739Registry updated 2026-11-05
Phase 2RecruitingTrial-stage medicine
Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06176989Registry updated 2026-11-05
Phase 2RecruitingTrial-stage medicine
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Where
- Aberdeen, Aitkin, Alcoa, Allentown, Alton, Ames, Anaconda, Anchorage, Ankeny, Ann Arbor, Arroyo Grande, Ashland, Atlanta, Aurora, Aventura, Baker City, Ballwin, Baltimore, Bardstown, Basking Ridge, Baton Rouge, Beavercreek, Bellevue, Bellingham, Belpre, Bend, Bethesda, Bethlehem, Bettendorf, Billings, Birmingham, Bloomington, Boardman, Boise, Bolivar, Bonne Terre, Boone, Bozeman, Brainerd, Branson, Brighton, Brooklyn, Brownstown, Bryan, Buffalo, Burbank, Burien, Burlington, Burnsville, Burr Ridge, Caldwell, Cambridge, Canton, Cape Girardeau, Carbondale, Caro, Carson City, Carterville, Carthage, Centerville, Centralia, Chanute, Chapel Hill, Charleston, Chelsea, Chicago, Chillicothe, Cincinnati, City of Saint Peters, Clackamas, Clarkston, Clinton Township, Clive, Clovis, Cody, Coeur d'Alene, Colorado Springs, Columbus, Commack, Coon Rapids, Coos Bay, Corbin, Council Bluffs, Covington, Creston, Creve Coeur, Cudahy, Dallas, Danville, Dayton, Dearborn, Decatur, Deer River, Delaware, Denver, Des Moines, Detroit, Detroit Lakes, Dixon, Dodge City, Dublin, Duluth, Durango, East China Township, East Stroudsburg, Eau Claire, Edina, Edmonds, Effingham, El Dorado, Emeryville, Emmett, Enumclaw, Erie, Eureka, Everett, Fairway, Fargo, Farmington, Federal Way, Fergus Falls, Findlay, Flint, Fort Dodge, Fort Lauderdale, Fort Smith, Fort Worth, Fosston, Franklin, Frederick, Fridley, Fruitland, Gahanna, Galesburg, Garden City, Germantown, Grafton, Grand Island, Great Bend, Great Falls, Green Bay, Greenbrae, Greensburg, Greenville, Grosse Pointe Woods, Grove City, Harrison, Hays, Hazleton, Helena, Henderson, Hendersonville, Hibbing, Homer Glen, Hot Springs, Independence, Iowa City, Issaquah, Jackson, Jamestown, Jefferson, Jefferson City, Jefferson Hills, Johns Creek, Joplin, Kalispell, Kansas City, Kearney, Kenner, Kennewick, Kenosha, Kettering, Kewanee, Kingman, Knoxville, Lacey, Lake Forest, Lake Success, Lakewood, Lancaster, Lansing, Las Vegas, Lawrence, Lawton, Lee's Summit, Lexington, Liberal, Lima, Lincoln, Littleton, Livonia, London, Longmont, Longview, Los Angeles, Louisville, Macomb, Manhattan, Mansfield, Maple Grove, Maplewood, Marietta, Marinette, Marion, Marlette, Marshalltown, Marshfield, Martinez, Marysville, Mattoon, Maywood, McPherson, Melrose Park, Meridian, Metairie, Miami Beach, Middletown, Milwaukee, Mineola, Minneapolis, Minocqua, Missoula, Monroeville, Monticello, Montvale, Mount Vernon, Mukwonago, Nampa, Nashville, Natrona Heights, Newark, Newberg, New Lenox, New Orleans, Newport Beach, New Richmond, Newton, New Ulm, New York, N. Huntingdon, Novi, Oakland, Oak Park, Oconomowoc, O'Fallon, Oklahoma City, Olathe, Omaha, Ontario, Oregon City, Orlando, Orland Park, Oshkosh, Ottawa, Pahrump, Papillion, Parker, Park Rapids, Parsons, Peabody, Pekin, Peoria, Perrysburg, Peru, Phoenix, Pittsburg, Pittsburgh, Pontiac, Port Huron, Portland, Portsmouth, Post Falls, Poulsbo, Pratt, Princeton, Pueblo, Racine, Redmond, Reno, Renton, Rice Lake, Richardson, Richmond, Robbinsdale, Rochester, Rochester Hills, Rolla, Saginaw, Sainte Genevieve, Saint Joseph, Saint Louis Park, Saint Paul, Salina, Sandpoint, Sandstone, San Luis Obispo, Santa Maria, Scottsdale, Seattle, Sedro-Woolley, Shakopee, Sheboygan, Shelby, Shelton, Shepherdsville, Sheridan, Shiloh, Silverdale, Springfield, Sterling Heights, Stevens Point, Stillwater, St Louis, Sullivan, Summit, Swansea, Syracuse, Tacoma, Tawas City, Toledo, Topeka, Troy, Tucson, Tulsa, Twin Falls, Two Rivers, Uniondale, Urbana, Vancouver, Virginia, Waconia, Walla Walla, Walnut Creek, Warren, Washington, Washington D.C., Waukee, Waukesha, Wauwatosa, Wellington, West Allis, West Bloomfield, West Branch, West Chester, West Des Moines, Westerville, Weston, Westwood, Wexford, Wichita, Willmar, Winchester, Winfield, Woodbury, Wyandotte, Wyoming, Yakima, Yelm, Yorkville, Youngstown, Ypsilanti, Zanesville
- Age
- 18 years and over
- People
- 314 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03866382Registry updated 2026-11-04
Phase 1Not yet recruitingTrial-stage medicine
A Study of 177Lu-DTPA-SC16.56 in People With Neuroendocrine Carcinomas of the Lung and Prostate
- Where
- Basking Ridge, Commack, Harrison, Middletown, Montvale, New York, Rockville Centre
- Age
- 18 years and over
- People
- 12
- Run by
- Memorial Sloan Kettering Cancer Center
See details and how to joinNCT06941480Registry updated 2026-11-04
Phase 2RecruitingTrial-stage medicine
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
- Where
- Ann Arbor, Baltimore, Bethesda, Boston, Chicago, Houston, Iowa City, Los Angeles, Nashville, New York, Philadelphia, St Louis, Warrenville
- Age
- 12 years and over
- People
- 355 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT04924075EU 2023-504853-11-00Registry updated 2026-11-03
Phase 2RecruitingTrial-stage medicine
Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells
- Where
- Baltimore, Chicago, Columbus, Dallas, Duarte, Houston, Lexington, Los Angeles, Madison, Sacramento, Winston-Salem
- Age
- 18 years and over
- People
- 35
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05691465Registry updated 2026-11-03
Phase 2RecruitingTrial-stage medicine
Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
- Where
- Albuquerque, Ankeny, Aurora, Aventura, Birmingham, Chicago, Clive, Columbus, Coral Gables, Crown Point, Deerfield Beach, DeKalb, Des Moines, Detroit, Geneva, Jacksonville, Lexington, Miami, New Lenox, North Miami, Oak Brook, Orland Park, Phoenix, Plantation, Rochester, Salt Lake City, San Francisco, Tucson, Warrenville, Waukee
- Age
- 18 years and over
- People
- 100 worldwide
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05773274Registry updated 2026-11-03
Phase 1RecruitingTrial-stage medicine
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
- Where
- Charlottesville, Columbus, Iowa City, Jacksonville, Lexington, Los Angeles, Nashville, Phoenix, Portland, Rochester, Salt Lake City, St Louis
- Age
- 18 years and over
- People
- 104 worldwide
- Run by
- RayzeBio, Inc.
See details and how to joinNCT07165132Registry updated 2026-11-03
No phaseRecruitingResearch participation
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 300
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT05237934Registry updated 2026-11-02
Phase 2RecruitingTrial-stage medicine
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
- Where
- Bethesda
- Age
- 18 years to 72 years
- People
- 285
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT03412877Registry updated 2026-10-30
Phase 2/3RecruitingTrial-stage medicine
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- Where
- Albuquerque, Bethesda, Beverly Hills, Birmingham, Boston, Buffalo, Chapel Hill, Charlottesville, Cleveland, Columbus, Dallas, Detroit, Durham, Fairfax, Fargo, Grand Rapids, Jacksonville, Knoxville, Lexington, Los Angeles, Metairie, Milwaukee, Nashville, New York, Omaha, Orlando, Palo Alto, Philadelphia, Phoenix, Pittsburgh, Portland, Rochester, Salt Lake City, Santa Monica, Seattle, St Louis, Tampa, Tucson, Vallejo, Washington D.C.
- Age
- 18 years and over
- People
- 440 worldwide
- Run by
- Exelixis
See details and how to joinNCT06943755EU 2025-521043-20-00Registry updated 2026-10-30
Phase 1RecruitingTrial-stage medicine
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
- Where
- Atlanta, Aurora, Columbus, Dallas, East Brunswick, Fairfax, Glendale, Greenville, Hackensack, Houston, Huntsville, Long Beach, Los Angeles, New Brunswick, New Haven, New Orleans, New York, Portland, San Antonio, San Francisco, Seattle
- Age
- 18 years and over
- People
- 120 worldwide
- Run by
- SystImmune Inc.
See details and how to joinNCT07080242Registry updated 2026-10-30
Phase 1RecruitingResearch participation
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
- Where
- Boston
- Age
- 18 years and over
- People
- 30
- Run by
- Brigham and Women's Hospital
See details and how to joinNCT06062745Registry updated 2026-10-29
Phase 2RecruitingResearch participation
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 320
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT06503146Registry updated 2026-10-29
Phase 1RecruitingTrial-stage medicine
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
- Where
- Bethesda
- Age
- 18 years to 120 years
- People
- 40
- Run by
- National Cancer Institute (NCI)
See details and how to joinNCT07509034Registry updated 2026-10-29
No phaseRecruitingResearch participation
Multicenter Study for External Validation of the TB-NET Score
- Where
- Boston, St Louis
- Age
- 18 years and over
- People
- 400 worldwide
- Run by
- Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
See details and how to joinNCT07903532Registry updated 2026-10-29
All Neuroendocrine tumours trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.